跳至主要内容
临床试验/NCT05842824
NCT05842824尚未招募不适用

An Observational Study of Patients With Autoimmune Disease

Target PharmaSolutions, Inc.0 个研究点目标入组 500,000 人开始时间: 2025年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500,000
主要终点
To characterize the natural history of disease in patients with autoimmune disease of various etiologies.

研究概览

简要总结

TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients at the time of enrollment with a diagnosis autoimmune disease by select ICD-10 codes in the EHR interface

排除标准

  • Manual removal (sponsor or site request)
  • No EHR interface encounter > 3 years
  • Engaged Cohort
  • Inclusion Criteria:
  • Adult patients diagnosed and managed for these conditions invited to participate
  • Ability to provide written informed consent
  • Exclusion Criteria:
  • Patient expressed desire to withdraw consent to complete PROs
  • Failure to complete PROs within 24 weeks of initial invitation
  • Greater than 24 months lapse of survey completion after baseline surveys completed
  • Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

结局指标

主要结局

To characterize the natural history of disease in patients with autoimmune disease of various etiologies.

时间窗: 15 Years

To assess safety and effectiveness of autoimmune disease treatments and treatments for complications of any related conditions

时间窗: 20 Years

次要结局

  • To select and evaluate quality of care measures for patients with autoimmune diseases(15 Years)
  • To evaluate provider management practices in the treatment of patients with autoimmune diseases(15 Years)
  • To evaluate longitudinal and patient reported outcomes in patients with autoimmune diseases(15 Years)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验